Cargando…

Is Ritonavir-Boosted Atazanavir a Risk for Cholelithiasis Compared to Other Protease Inhibitors?

OBJECTIVE: To compare the incidence of complicated cholelithiasis in patients receiving ritonavir-boosted atazanavir (ATV/r)- containing antiretroviral therapy with those on other protease inhibitors (PIs). DESIGN: We conducted a single-center retrospective cohort study of patients who started eithe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamada, Yohei, Nishijima, Takeshi, Komatsu, Hirokazu, Teruya, Katsuji, Gatanaga, Hiroyuki, Kikuchi, Yoshimi, Oka, Shinichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3713059/ https://www.ncbi.nlm.nih.gov/pubmed/23875004 http://dx.doi.org/10.1371/journal.pone.0069845

Ejemplares similares

Ritonavir-Boosted Darunavir Is Rarely Associated with Nephrolithiasis Compared with Ritonavir-Boosted Atazanavir in HIV-Infected Patients
por: Nishijima, Takeshi, et al.
Publicado: (2013)

Cerebral Syphilitic Gumma within 5 Months of Syphilis in HIV-Infected Patient
por: Tsuboi, Motoyuki, et al.
Publicado: (2016)

Mortality and causes of death in people living with HIV in the era of combination antiretroviral therapy compared with the general population in Japan
por: Nishijima, Takeshi, et al.
Publicado: (2020)

Preemptive Therapy Prevents Cytomegalovirus End-Organ Disease in Treatment-Naïve Patients with Advanced HIV-1 Infection in the HAART Era
por: Mizushima, Daisuke, et al.
Publicado: (2013)

High Mortality of Disseminated Non-Tuberculous Mycobacterial Infection in HIV-Infected Patients in the Antiretroviral Therapy Era
por: Kobayashi, Tetsuro, et al.
Publicado: (2016)

Routine Eye Screening by an Ophthalmologist Is Clinically Useful for HIV-1-Infected Patients with CD4 Count Less than 200 /μL
por: Nishijima, Takeshi, et al.
Publicado: (2015)

A 21-Day of Adjunctive Corticosteroid Use May Not Be Necessary for HIV-1-Infected Pneumocystis Pneumonia with Moderate and Severe Disease
por: Shibata, Satoshi, et al.
Publicado: (2015)

Impact of Small Body Weight on Tenofovir-Associated Renal Dysfunction in HIV-Infected Patients: A Retrospective Cohort Study of Japanese Patients
por: Nishijima, Takeshi, et al.
Publicado: (2011)

Renal Function Declines More in Tenofovir- than Abacavir-Based Antiretroviral Therapy in Low-Body Weight Treatment-Naïve Patients with HIV Infection
por: Nishijima, Takeshi, et al.
Publicado: (2012)

Case report: new development of fibrosing interstitial lung disease triggered by HIV-related pneumocystis pneumonia
por: Suzuki, Tetsuya, et al.
Publicado: (2019)

Traditional but Not HIV-Related Factors Are Associated with Nonalcoholic Fatty Liver Disease in Asian Patients with HIV-1 Infection
por: Nishijima, Takeshi, et al.
Publicado: (2014)

Increased risk of non-AIDS-defining cancers in Asian HIV-infected patients: a long-term cohort study
por: Nagata, Naoyoshi, et al.
Publicado: (2018)

Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers
por: Dickinson, Laura, et al.
Publicado: (2009)

Prevalence and factors associated with chronic kidney disease and end-stage renal disease in HIV-1-infected Asian patients in Tokyo
por: Nishijima, Takeshi, et al.
Publicado: (2017)

Effect of Tenofovir Disoproxil Fumarate on Incidence of Chronic Kidney Disease and Rate of Estimated Glomerular Filtration Rate Decrement in HIV-1–Infected Treatment-Naïve Asian Patients: Results from 12-Year Observational Cohort
por: Suzuki, Soichiro, et al.
Publicado: (2017)

881. Long-term Weight Gain After Initiating Combination Antiretroviral Therapy in Treatment-naïve Asian People Living with HIV
por: Ando, Naokatsu, et al.
Publicado: (2021)

Prevalence of Anal Human Papillomavirus Infection and Risk Factors among HIV-positive Patients in Tokyo, Japan
por: Nagata, Naoyoshi, et al.
Publicado: (2015)

Incidence and Risk Factors for Incident Syphilis among HIV-1-Infected Men Who Have Sex with Men in a Large Urban HIV Clinic in Tokyo, 2008−2015
por: Nishijima, Takeshi, et al.
Publicado: (2016)

Application of The Change Point Analysis to The Long-Term Restoration of CD4 Count Among Well-Controlled HIV-1 Infected Patients Who Started Antiretroviral Therapy
por: Yoshikazu, Mutoh, et al.
Publicado: (2017)

Illicit Drug Use Is a Significant Risk Factor for Loss to Follow Up in Patients with HIV-1 Infection at a Large Urban HIV Clinic in Tokyo
por: Nishijima, Takeshi, et al.
Publicado: (2013)

High Prevalence of Illicit Drug Use in Men Who Have Sex with Men with HIV-1 Infection in Japan
por: Nishijima, Takeshi, et al.
Publicado: (2013)

Increases in Entamoeba histolytica Antibody–Positive Rates in Human Immunodeficiency Virus–Infected and Noninfected Patients in Japan: A 10-Year Hospital-Based Study of 3,514 Patients
por: Yanagawa, Yasuaki, et al.
Publicado: (2016)

Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling
por: Montanha, Maiara Camotti, et al.
Publicado: (2021)

Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric population
por: Rusconi, Stefano, et al.
Publicado: (2012)

Serum lipid profiles among patients initiating ritonavir-boosted atazanavir versus efavirenz-based regimens
por: Ganesan, Anuradha, et al.
Publicado: (2009)

Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling
por: Montanha, Maiara Camotti, et al.
Publicado: (2022)

Pharmacokinetics of Rifabutin in Japanese HIV-Infected Patients with or without Antiretroviral Therapy
por: Tanuma, Junko, et al.
Publicado: (2013)

Combination of Clindamycin and Azithromycin as Alternative Treatment for Toxoplasma gondii Encephalitis
por: Shiojiri, Daisuke, et al.
Publicado: (2019)

Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients
por: Antoniou, Tony, et al.
Publicado: (2017)

Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disorders
por: Uemura, Haruka, et al.
Publicado: (2017)

Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort
por: Postorino, Maria Concetta, et al.
Publicado: (2017)

What Triggers a Diagnosis of HIV Infection in the Tokyo Metropolitan Area? Implications for Preventing the Spread of HIV Infection in Japan
por: Nishijima, Takeshi, et al.
Publicado: (2015)

Validation of Simultaneous Quantitative Method of HIV Protease Inhibitors Atazanavir, Darunavir and Ritonavir in Human Plasma by UPLC-MS/MS
por: Mishra, Tulsidas, et al.
Publicado: (2014)

Metabolic: week 48 comparison of metabolic parameters and biomarkers in subjects receiving darunavir/ritonavir or atazanavir/ritonavir
por: Overton, T, et al.
Publicado: (2010)

Comparative gender analysis of the efficacy and safety of atazanavir/ritonavir and lopinavir/ritonavir at 96 weeks in the CASTLE study
por: Squires, Kathleen E., et al.
Publicado: (2011)

An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir
por: Laker, Eva Agnes Odongpiny, et al.
Publicado: (2019)

Emergence of CXCR4-tropic HIV-1 variants followed by rapid disease progression in hemophiliac slow progressors
por: Hayashida, Tsunefusa, et al.
Publicado: (2017)

Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
por: Broder, MS, et al.
Publicado: (2010)

Safety and Tolerability of High Dose Atazanavir–Ritonavir and Lopinavir–Ritonavir in Pregnant Women Living with Human Immunodeficiency Virus
por: McLaughlin, Milena M, et al.
Publicado: (2017)

Anal human papillomavirus infection and its relationship with abnormal anal cytology among MSM with or without HIV infection in Japan
por: Shiojiri, Daisuke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eni8h8cmd6hksl2epvcpi3nrpq